» Articles » PMID: 9700637

Identification of an Immunodominant Sequential Epitope in Glycoprotein G of Herpes Simplex Virus Type 2 That is Useful for Serotype-specific Diagnosis

Overview
Journal J Med Virol
Specialty Microbiology
Date 1998 Aug 13
PMID 9700637
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A series of 67 oligopeptides that spanned the open reading frame of herpes simplex virus type 2 (HSV-2) glycoprotein G (gG2) were synthesized and tested for reactivity with 173 serum specimens collected from 117 individuals. The oligopeptides were made as multiple antigenic peptides consisting of four copies of a unique sequence attached to a branched lysine core and separated from the core by four glycine residues. The sera included HSV antibody-negative samples as well as sera from individuals from whom HSV had been isolated. Isolated viruses were typed by indirect fluorescence using a panel of type-specific monoclonal antibodies. One peptide, corresponding to residues 561 to 578 of gG2, did not react with any sera lacking HSV-specific antibodies of with sera from HSV-1-infected individuals, but did react with sera from HSV-2-infected individuals. For sera taken seven or more days after initialclinical lesions, the detection rate of the peptide was 92% (47/51), comparable with the 98% (50/51) of truncated glycoprotein D, a sensitive type-common reagent. We conclude that this peptide, of structure (PEEFEGAGDGEPPEDDDSG4)K3A, is an immunodominant type-specific epitope for human antibodies and should be useful for type-specific serodiagnosis of HSV-2. Surprisingly, the epitope lies within one of the most conserved regions of gG1 and gG2. The test can distinguish an initial HSV-2 infection in the presence of a preexisting HSV-1 infection.

Citing Articles

Human Antibodies against Herpes Simplex Virus 2 Glycoprotein G Do Not Neutralize but Mediate Antibody-Dependent Cellular Cytotoxicity.

Liljeqvist J, Onnheim K, Tunback P, Eriksson K, Gorander S, Backstrom M Antibodies (Basel). 2024; 13(2).

PMID: 38804308 PMC: 11130973. DOI: 10.3390/antib13020040.


Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus-Seronegative Recipients of the HSV529 Vaccine.

Wang K, Dropulic L, Bozekowski J, Pietz H, Jegaskanda S, Dowdell K J Infect Dis. 2021; 224(9):1509-1519.

PMID: 33718970 PMC: 8599754. DOI: 10.1093/infdis/jiab139.


A general approach for predicting protein epitopes targeted by antibody repertoires using whole proteomes.

Paull M, Johnston T, Ibsen K, Bozekowski J, Daugherty P PLoS One. 2019; 14(9):e0217668.

PMID: 31490930 PMC: 6730857. DOI: 10.1371/journal.pone.0217668.


Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.

Liu T, Liu J, Yu H, Si G, Hu J, Li J Singapore Med J. 2014; 56(6):346-52.

PMID: 25532518 PMC: 4469854. DOI: 10.11622/smedj.2014197.


Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis.

Clo E, Kracun S, Nudelman A, Jensen K, Liljeqvist J, Olofsson S J Virol. 2012; 86(11):6268-78.

PMID: 22491453 PMC: 3372205. DOI: 10.1128/JVI.00392-12.